Loading...
By the Editors
The U.S. Department of Health and Human Services now recommends that clinicians "strongly consider" prescribing or coprescribing naloxone in patients at elevated risk for opioid overdose.
These include patients prescribed opioids who receive relatively high doses (e.g., >50 MME/day), those who take other drugs that can enhance opioid complications (e.g., benzodiazepines), or those with underlying health conditions (e.g., chronic obstructive pulmonary disease).
This comes a day after an FDA advisory panel voted 12 to 11 to change opioid labels so that they recommend coprescription of naloxone, Reuters reports. One FDA adviser who voted in favor of the measure said that prescribing naloxone could prompt a discussion between clinicians and patients.
Comment
LINK(S):
HHS news release (Free)
Reuters story (Free)
Background: NEJM Journal Watch General Medicine coverage of prescribing naloxone for patients taking opioids for chronic pain (Your NEJM Journal Watch registration required)